Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our history
    • Our people
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in review 2018
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • What's happening in each category?
    • About our role in device management
    • Consultation on managing fairer access to hospital medical devices
    • Device Advice
  • News
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • One Heart Many Lives
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
  • Pacific
    • Pacific
    • Pacific responsiveness strategy
    • Pacific action plan
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…

<< Part II & III - Therapeutic Groups

Online HML - December 2019

Info

Nervous System
    • Part II & III - Therapeutic Groups
Agents for Parkinsonism and Related Disorders Agents for Essential Tremor, Chorea and Related Disorders; Anticholinergics; Dopamine Agonists and Related Agents
Anaesthetics General Anaesthetics; Local Anaesthetics
Analgesics Non-Opioid Analgesics; Opioid Analgesics
Antidepressants Cyclic and Related Agents; Monoamine-Oxidase Inhibitors - Non-Selective; Monoamine-Oxidase Type A Inhibitors; Other Antidepressants; Selective Serotonin Reuptake Inhibitors
Antiepilepsy Drugs Agents for the Control of Status Epilepticus; Control of Epilepsy
Antimigraine Preparations Acute Migraine Treatment; Prophylaxis of Migraine
Antinausea and Vertigo Agents Antinausea and Vertigo Agents
Antipsychotic Agents Depot Injections; General
Anxiolytics Anxiolytics
Multiple Sclerosis Treatments Multiple Sclerosis Treatments; Other Multiple Sclerosis Treatments
Sedatives and Hypnotics Sedatives and Hypnotics
Stimulants / ADHD Treatments Stimulants / ADHD Treatments
Treatments for Dementia Treatments for Dementia
Treatments for Substance Dependence Treatments for Substance Dependence

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • This site is operated by PHARMAC, the Pharmaceutical Management Agency.

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed

Back to top

New Zealand Government